Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Cardiomyopathy | Research

Geospatial analysis as a tool to identify target areas for Chagas disease education for healthcare providers

Authors: Gerardo J. Pacheco, Lawrence Fulton, Jose Betancourt, Ram Shanmugam, Paula Stigler Granados

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Chagas Disease (CD) is a neglected zoonotic disease of the Americas. It can be fatal if not diagnosed and treated in its early stages. Using geospatial and sensitivity analysis, this study focuses on understanding how to better allocate resources and educational information to areas in the United States, specifically Texas, that have the potential for increased risk of CD cases and the associated costs of addressing the disease. ICD-9 and 10 inpatient hospital diagnostic codes were used to illustrate the salience of potentially missed CD diagnoses (e.g., cardiomyopathic diagnoses) and where these are occurring with more frequency. Coding software along with GIS and Microsoft Excel 3D mapping were used to generate maps to illustrate where there may be a need for increased statewide surveillance and screening of populations at greater risk for CD. The CD cases reported to the Texas Department of State Healthcare Services (TxDSHS) are not homogenously dispersed throughout the state but rather, reveal that the incidences are in clusters and primarily in urban areas, where there is increased access to physician care, CD research and diagnostic capabilities.
Literature
1.
go back to reference Montgomery SP, et al. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hyg. 2014;90(5):814–8.CrossRef Montgomery SP, et al. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hyg. 2014;90(5):814–8.CrossRef
2.
go back to reference Bern C, et al. Trypanosoma cruzi and Chagas’ Disease in the United States. Clin Microbiol Rev. 2011;24(4):655–81.CrossRef Bern C, et al. Trypanosoma cruzi and Chagas’ Disease in the United States. Clin Microbiol Rev. 2011;24(4):655–81.CrossRef
3.
go back to reference Bern C. Antitrypanosomal therapy for chronic Chagas’ disease. N Engl J Med. 2011;364(26):2527–34.CrossRef Bern C. Antitrypanosomal therapy for chronic Chagas’ disease. N Engl J Med. 2011;364(26):2527–34.CrossRef
4.
go back to reference Bern C et al. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019; 33(1). Bern C et al. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019; 33(1).
5.
go back to reference Lidani KCF, et al. Chagas disease: from discovery to a worldwide health problem. Front Public Health. 2019;7:166.CrossRef Lidani KCF, et al. Chagas disease: from discovery to a worldwide health problem. Front Public Health. 2019;7:166.CrossRef
8.
go back to reference Manne-Goehler J, et al. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016;10(11): e0005033.CrossRef Manne-Goehler J, et al. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016;10(11): e0005033.CrossRef
9.
go back to reference Garcia MN, et al. Knowledge, attitudes, and practices of Texas hunters: a potentially high-risk population for exposure to the parasite that causes Chagas disease. Parasit Vectors. 2015;8:197.CrossRef Garcia MN, et al. Knowledge, attitudes, and practices of Texas hunters: a potentially high-risk population for exposure to the parasite that causes Chagas disease. Parasit Vectors. 2015;8:197.CrossRef
10.
go back to reference Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402.CrossRef Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402.CrossRef
12.
go back to reference Garcia MN, et al. Historical perspectives on the epidemiology of human Chagas disease in Texas and recommendations for enhanced understanding of clinical Chagas disease in the Southern United States. PLoS Negl Trop Dis. 2015;9(11): e0003981.CrossRef Garcia MN, et al. Historical perspectives on the epidemiology of human Chagas disease in Texas and recommendations for enhanced understanding of clinical Chagas disease in the Southern United States. PLoS Negl Trop Dis. 2015;9(11): e0003981.CrossRef
14.
go back to reference Torpy JM, Burke AE, Glass RM. JAMA patient page. Chagas disease. JAMA. 2007;298(18):2222.CrossRef Torpy JM, Burke AE, Glass RM. JAMA patient page. Chagas disease. JAMA. 2007;298(18):2222.CrossRef
15.
go back to reference Guide for surveillance, prevention, control and clinical management of acute foodborne Chagas disease. 2009, PANAFTOSA-VP, PAHO, WHO Guide for surveillance, prevention, control and clinical management of acute foodborne Chagas disease. 2009, PANAFTOSA-VP, PAHO, WHO
16.
go back to reference Bern C, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298(18):2171–81.CrossRef Bern C, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298(18):2171–81.CrossRef
17.
go back to reference Torrico F, et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect Dis. 2021;21(8):1129–40.CrossRef Torrico F, et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect Dis. 2021;21(8):1129–40.CrossRef
18.
go back to reference Morillo CA, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373(14):1295–306.CrossRef Morillo CA, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373(14):1295–306.CrossRef
19.
go back to reference Mitelman JE. Consensus statement on Chagas-Mazza disease. Rev Argent Cardiol. 2011;79(6):544–64. Mitelman JE. Consensus statement on Chagas-Mazza disease. Rev Argent Cardiol. 2011;79(6):544–64.
20.
go back to reference Bonney KM, Engman DM. Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med. 2008;8(6):510–8.CrossRef Bonney KM, Engman DM. Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med. 2008;8(6):510–8.CrossRef
21.
go back to reference Kierszenbaum F. Chagas’ disease and the autoimmunity hypothesis. Clin Microbiol Rev. 1999;12(2):210–23.CrossRef Kierszenbaum F. Chagas’ disease and the autoimmunity hypothesis. Clin Microbiol Rev. 1999;12(2):210–23.CrossRef
22.
go back to reference Viotti R, et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2014;58(2):635–9.CrossRef Viotti R, et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2014;58(2):635–9.CrossRef
23.
go back to reference Hotez PJ, et al. Chagas disease: “the new HIV/AIDS of the Americas.” PLoS Negl Trop Dis. 2012;6(5): e1498.CrossRef Hotez PJ, et al. Chagas disease: “the new HIV/AIDS of the Americas.” PLoS Negl Trop Dis. 2012;6(5): e1498.CrossRef
24.
go back to reference Marin-Neto JA, et al. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109–23.CrossRef Marin-Neto JA, et al. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109–23.CrossRef
25.
go back to reference Hyson P, et al. Experiences with diagnosis and treatment of Chagas disease at a United States teaching hospital-clinical features of patients with positive screening serologic testing. Trop Med Infect Dis. 2021;6(2):93.CrossRef Hyson P, et al. Experiences with diagnosis and treatment of Chagas disease at a United States teaching hospital-clinical features of patients with positive screening serologic testing. Trop Med Infect Dis. 2021;6(2):93.CrossRef
26.
go back to reference Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49(5):e52–4.CrossRef Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49(5):e52–4.CrossRef
27.
go back to reference Forsyth CJ, et al. Current gaps and needs for increasing access to healthcare for people with Chagas disease in the USA. Curr Trop Med Rep. 2019;6(1):13–22.CrossRef Forsyth CJ, et al. Current gaps and needs for increasing access to healthcare for people with Chagas disease in the USA. Curr Trop Med Rep. 2019;6(1):13–22.CrossRef
29.
go back to reference Garcia MN, et al. Evidence of autochthonous Chagas disease in southeastern Texas. Am J Trop Med Hyg. 2015;92(2):325–30.CrossRef Garcia MN, et al. Evidence of autochthonous Chagas disease in southeastern Texas. Am J Trop Med Hyg. 2015;92(2):325–30.CrossRef
30.
go back to reference Gunter SM, et al. Likely autochthonous transmission of Trypanosoma cruzi to Humans, South Central Texas, USA. Emerg Infect Dis. 2017;23(3):500–3.CrossRef Gunter SM, et al. Likely autochthonous transmission of Trypanosoma cruzi to Humans, South Central Texas, USA. Emerg Infect Dis. 2017;23(3):500–3.CrossRef
31.
go back to reference Cantey PT, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52(9):1922–30.CrossRef Cantey PT, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52(9):1922–30.CrossRef
32.
go back to reference Garcia MN, et al. Development of Chagas cardiac manifestations among Texas blood donors. Am J Cardiol. 2015;115(1):113–7.CrossRef Garcia MN, et al. Development of Chagas cardiac manifestations among Texas blood donors. Am J Cardiol. 2015;115(1):113–7.CrossRef
33.
go back to reference Garcia MN, et al. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. 2016;144(5):1010–3.CrossRef Garcia MN, et al. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. 2016;144(5):1010–3.CrossRef
34.
go back to reference Conners EE, et al. A global systematic review of Chagas disease prevalence among migrants. Acta Trop. 2016;156:68–78.CrossRef Conners EE, et al. A global systematic review of Chagas disease prevalence among migrants. Acta Trop. 2016;156:68–78.CrossRef
35.
go back to reference World Health Organization et al. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. 2013, Geneva, Switzerland: World Health Organization. xii, 138 p. World Health Organization et al. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. 2013, Geneva, Switzerland: World Health Organization. xii, 138 p.
36.
go back to reference Stigler Granados P, et al. Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. BMC Infect Dis. 2020;20(743):1–6. Stigler Granados P, et al. Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. BMC Infect Dis. 2020;20(743):1–6.
37.
go back to reference Pacheco GJ, Stigler Granados P, Betancourt J. Shaping recommendations and healthcare provider education on Chagas disease from a mixed methods baseline exploratory study. Unpublished. Pacheco GJ, Stigler Granados P, Betancourt J. Shaping recommendations and healthcare provider education on Chagas disease from a mixed methods baseline exploratory study. Unpublished.
38.
go back to reference Mahoney West H, et al. Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers. PLoS ONE. 2021;16(2): e0246783.CrossRef Mahoney West H, et al. Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers. PLoS ONE. 2021;16(2): e0246783.CrossRef
46.
go back to reference Lynn MK, et al. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205: 105361.CrossRef Lynn MK, et al. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205: 105361.CrossRef
47.
go back to reference Sarkar S, et al. Chagas disease risk in Texas. PLoS Negl Trop Dis. 2010;4(10):e836.CrossRef Sarkar S, et al. Chagas disease risk in Texas. PLoS Negl Trop Dis. 2010;4(10):e836.CrossRef
48.
go back to reference Forsyth CJ, et al. Recommendations for screening and diagnosis of Chagas disease in the United States. J Infect Dis. 2021;225:1601–10.CrossRef Forsyth CJ, et al. Recommendations for screening and diagnosis of Chagas disease in the United States. J Infect Dis. 2021;225:1601–10.CrossRef
50.
go back to reference Webber BJ, et al. A case of Chagas cardiomyopathy following infection in south central Texas. US Army Med Dep J. 2017;1–17:55–9. Webber BJ, et al. A case of Chagas cardiomyopathy following infection in south central Texas. US Army Med Dep J. 2017;1–17:55–9.
51.
go back to reference Noble D, et al. Feasibility study of geospatial mapping of chronic disease risk to inform public health commissioning. BMJ Open. 2012;2(1): e000711.CrossRef Noble D, et al. Feasibility study of geospatial mapping of chronic disease risk to inform public health commissioning. BMJ Open. 2012;2(1): e000711.CrossRef
52.
go back to reference Echavarria NG, et al. Chagas disease: chronic Chagas cardiomyopathy. Curr Probl Cardiol. 2021;46(3): 100507.CrossRef Echavarria NG, et al. Chagas disease: chronic Chagas cardiomyopathy. Curr Probl Cardiol. 2021;46(3): 100507.CrossRef
53.
go back to reference Nolan MS, et al. Continuing evidence of Chagas disease along the Texas-Mexico border. PLoS Negl Trop Dis. 2018;12(11): e0006899.CrossRef Nolan MS, et al. Continuing evidence of Chagas disease along the Texas-Mexico border. PLoS Negl Trop Dis. 2018;12(11): e0006899.CrossRef
54.
go back to reference Lima NA, et al. Hospitalization for Chagas heart disease in the United States from 2002 to 2017. JAMA Netw Open. 2021;4(10): e2129959.CrossRef Lima NA, et al. Hospitalization for Chagas heart disease in the United States from 2002 to 2017. JAMA Netw Open. 2021;4(10): e2129959.CrossRef
55.
go back to reference Hochberg NS et al. Chagas Disease in the United States: a perspective on diagnostic testing limitations and next steps. Am J Trop Med Hyg. 2021. Hochberg NS et al. Chagas Disease in the United States: a perspective on diagnostic testing limitations and next steps. Am J Trop Med Hyg. 2021.
56.
go back to reference Stigler Granados P et al. Assessing healthcare providers’ knowledge and awareness of Chagas disease utilizing the extension for community healthcare outcomes model. Unpublished. Stigler Granados P et al. Assessing healthcare providers’ knowledge and awareness of Chagas disease utilizing the extension for community healthcare outcomes model. Unpublished.
Metadata
Title
Geospatial analysis as a tool to identify target areas for Chagas disease education for healthcare providers
Authors
Gerardo J. Pacheco
Lawrence Fulton
Jose Betancourt
Ram Shanmugam
Paula Stigler Granados
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Cardiomyopathy
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07577-y

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.